APA (7th ed.) Citation

A, G., C, M., HV, P., EC, L., J, S., CS, C., . . . CR, L. (2026). Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. Nature microbiology, 11(4), 1100. https://doi.org/10.1038/s41564-026-02285-8

Chicago Style (17th ed.) Citation

A, Glascock, et al. "Empiric Azithromycin Alters the Upper Respiratory Microbiome and Resistome Without Anti-inflammatory Benefit in COVID-19." Nature Microbiology 11, no. 4 (2026): 1100. https://doi.org/10.1038/s41564-026-02285-8.

MLA (9th ed.) Citation

A, Glascock, et al. "Empiric Azithromycin Alters the Upper Respiratory Microbiome and Resistome Without Anti-inflammatory Benefit in COVID-19." Nature Microbiology, vol. 11, no. 4, 2026, p. 1100, https://doi.org/10.1038/s41564-026-02285-8.